Since immune checkpoints may also promote pathogen persistence and many infections induce IDO activity, there may also be opportunities to use IDO inhibitors to reduce pathogen burdens and promote pathogen clearance in patients with chronic infections. The gene discussed is IDO1; the disease is infection.